Mb, Levis & Associates, LLC Moderna, Inc. Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 127 shares of MRNA stock, worth $3,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127
Previous 127
-0.0%
Holding current value
$3,535
Previous $5.28 Million
31.83%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
911Shares Held
238MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.12 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$712 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$695 Million0.64% of portfolio
-
State Street Corp Boston, MA17.6MShares$489 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$203 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...